来自MSN11 个月
Merck Highlights Data From Multiple Phase 3 Trials For Its Investigational Pneumococcal ...
In adults 18 years of age and older living with HIV, V116 elicited comparable immune responses to PCV15+PPSV23 for all 13 shared serotypes and higher immune responses for the eight serotypes ...